Phase 2 Higher Risk Myelodysplastic Syndromes Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
Acute Lymphoblastic LeukaemiaHigher Risk Myelodysplastic SyndromesAcute Myeloid Leukaemia
AstraZeneca84 enrolled30 locationsNCT07155226
Recruiting
Phase 2
A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes
Higher Risk Myelodysplastic Syndromes
Akeso90 enrolled15 locationsNCT06196203
Recruiting
Phase 1Phase 2
VA Conditioning Regimen Allo-HSCT for Elderly Higher-risk MDS
Higher Risk Myelodysplastic Syndromes
Navy General Hospital, Beijing54 enrolled1 locationNCT06471946